This topic contains a solution. Click here to go to the answer

Author Question: You connect an intubated patient to an air-entrainment nebulizer system through a T tube set at 60 ... (Read 30 times)

genevieve1028

  • Hero Member
  • *****
  • Posts: 601
You connect an intubated patient to an air-entrainment nebulizer system through a T tube set at 60 with an input flow of 15 L/min. Toward the middle of inspiration, you observe that mist stops exiting from the open end of the T tube.
 
  What does this indicate?
  a. Flow is adequate to meet patient needs.
  b. Patient has a low inspiratory flow rate.
  c. Flowmeter must be calibrated.
  d. Patient is not receiving 60 O2.

Question 2

To ensure the prescribed FiO2 for a patient receiving 65 O2, you apply a closed reservoir deliv-ery system with a one-way expiratory valve. What other component must be included in this sys-tem to ensure a fail-safe operation?
 
  a. Water trap
  b. High-pressure alarm
  c. Emergency inlet valve
  d. Low-pressure alarm



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

potomatos

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

ANS: D
As long as mist can be seen escaping throughout inspiration, flow is adequate to meet the pa-tient's needs, and the delivered FiO2 is ensured.

Answer to Question 2

ANS: C
These systems must be equipped with an emergency inlet valve that allows room air breathing in the event of source gas failure.




genevieve1028

  • Member
  • Posts: 601
Reply 2 on: Jul 16, 2018
Thanks for the timely response, appreciate it


Mochi

  • Member
  • Posts: 300
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

In 1844, Charles Goodyear obtained the first patent for a rubber condom.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

For a complete list of videos, visit our video library